Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO)

80 filings reported holding MREO - Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares as of Q1 2021.
Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 90.2M shares of 791M outstanding shares and own 11.41% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (17.3M shares), Point72 Asset Management, L.P. (8.28M shares), BAKER BROS. ADVISORS LP (6.72M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (6.37M shares), BOXER CAPITAL, LLC (6.23M shares), PERCEPTIVE ADVISORS LLC (6M shares), Rock Springs Capital Management LP (4.49M shares), Vivo Capital, LLC (4.22M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (2.98M shares), and Rubric Capital Management LP (2.91M shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.